Successful percutaneous bioprosthetic Medtronic CoreValve implantation (TAVI) in a very high surgical risk patient

On December 19, 2012 we successfully implanted the bioprosthetic valve Medtronic CoreValve in a 76-year-old female patient who was suffering from severe aortic valve stenosis, and was very symptomatic (dyspnea, angina) with minimal physical activity. Due to previous heart surgery and multiple comorbidities, the patient was considered of very high surgical risk. The operation was completed in 2 hours, without complications, and the patient was discharged in 4 days. Two months after the procedure the patient is feeling good and has normal daily activity.

 

Posted in Valvular Heart Desease Tagged with: , , , ,

Contact Info

Apostolos Tzikas, MD, PhD, FESC
Interventional Cardiologist
Thessaloniki - Center,
88 Tsimiski St., 6th floor
Tel (morning): 2310.380.189,
Tel (afternoon): 2310.263.060
Fax: 2310.341.828
E-Mail: [email protected]
Research